Hemo Organic Promoter Selling (Off-Market): ₹0.09 Cr
Hemo Organic promoter Dineshbhai Shanabhai Patel sold 155,986 shares off-market for ₹0.09 Cr, cutting stake from 2.40% to 0.13%.
- Value
- ₹0.09 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Hemo Organic promoter Dineshbhai Shanabhai Patel sold 155,986 shares off-market for ₹0.09 Cr, cutting stake from 2.40% to 0.13%.
Promoter Dineshbhai Patel disposed 1,55,986 Hemo Organic shares off-market on 24 Oct 2026, cutting his stake to 0.13%. No transaction value was disclosed in the filing.
Hemo Organic Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Hemo Organic Ltd reported revenue from operations of ₹1.4 Cr and net profit of ₹0 Cr for Q2 FY27.
Hemo Organic Limited has scheduled a board meeting on October 17, 2026, to consider and approve its un-audited financial results for the quarter and half-year ended September 30, 2026.
Hemo Organic Limited announced that the proposed appointment of Mrs. Pratibha Sharma as Company Secretary and Compliance Officer has been withdrawn. The appointment did not take effect.
Hemo Organic Ltd has filed its quarterly shareholding pattern for the period ended September 2026, as per regulatory requirements.
Hemo Organic Limited's board meeting deferred the proposal for raising funds. The decision will be taken up at a subsequent meeting of the board.
Hemo Organic Limited has appointed Mrs. Pratibha Sharma as Company Secretary and Compliance Officer, effective October 3, 2026.
Hemo Organic's board approved increasing authorised share capital to Rs. 125 Crore and amended the main objects clause to include diamond and real estate business activities.
Hemo Organic Limited has scheduled a board meeting for October 3, 2026, to consider a proposal for raising funds through various permissible modes.
Directors' relatives and the Jasani Family Private Trust acquired a total of 4,11,972 shares worth Rs. 0.24 Crore via off-market transactions.
Hemo Organic Ltd allotted 34 lakh equity shares upon conversion of warrants to non-promoter entities. The company received Rs. 3.1875 Crore as the balance consideration.
Non-promoter Dharmendrabhai Becharbhai Jasani acquired 1,11,341 shares of Hemo Organic Ltd via on-market purchase, increasing his stake in the company.
Hemo Organic promoter Dineshbhai Shanabhai Patel sold 60,000 equity shares via an off-market transaction. This disposal reduced the promoter's stake from 6.49% to 4.76%.
Promoter Dineshbhai Shanabhai Patel sold 3.12 lakh shares of Hemo Organic Ltd via an off-market deal valued at ₹0.19 Crore.
Promoters of Hemo Organic are transferring 5.68 lakh shares (16.38% stake) to external buyers via an off-market Share Purchase Agreement for ₹0.34 Crore.
Promoters of Hemo Organic Ltd entered into separate Share Purchase Agreements to sell 5,67,958 equity shares in an off-market transaction. Financial consideration remains undisclosed.
Hemo Organic's Company Secretary and Compliance Officer, Ms. Yukta Prakash Patel, has resigned effective September 19, 2026, citing personal reasons.
Hemo Organic Ltd scheduled a board meeting for September 23, 2026, to discuss a proposal for raising funds through the issuance of securities.
Hemo Organic Ltd received the 2nd tranche of consideration worth ₹2.76 Crore for convertible warrants from non-promoter allottees, progressing towards future equity share conversion.